May 12, 2006 | Applied Biosystems now offers 300 individual TaqMan MicroRNA Assays for human, mouse, and rat studies. The assays are based on a two-step process using Applied Biosystems’ proprietary stem-loop technology for reverse transcription of the mature microRNA followed by quantitative real-time PCR. The company says in preliminary studies, the assays were able to quantify microRNAs in samples as small as 25 picograms of total RNA and discriminate between highly homologous mature microRNAs. They were also shown to be highly reliable and quantitative for screening microRNA biomarkers that distinguish tumor types.
Vendor: Applied Biosystems
Product: TaqMan MicroRNA Assays
For more information: www.appliedbiosystems.com